Sabra Health Care REIT Reports Officer/Director Changes, Comp Arrangements
Ticker: SBRA · Form: 8-K · Filed: Jan 4, 2024 · CIK: 1492298
| Field | Detail |
|---|---|
| Company | Sabra Health Care Reit, Inc. (SBRA) |
| Form Type | 8-K |
| Filed Date | Jan 4, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $400,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Sabra Health Care REIT just filed an 8-K about executive changes and pay, keep an eye out for details.**
AI Summary
Sabra Health Care REIT, Inc. filed an 8-K on January 4, 2024, reporting an event that occurred on December 29, 2023. This filing indicates changes related to the departure or election of directors, appointment of officers, and compensatory arrangements for certain officers. While specific names or dollar amounts are not detailed in this summary, the filing signals potential shifts in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should monitor subsequent disclosures for details on these changes, as they could influence future stock performance.
Why It Matters
Changes in executive leadership or compensation can signal strategic shifts or financial health, directly impacting investor confidence and the company's future trajectory.
Risk Assessment
Risk Level: medium — The filing indicates changes in leadership and compensation, which can introduce uncertainty regarding future company strategy and performance until specific details are disclosed.
Analyst Insight
A smart investor would monitor Sabra Health Care REIT, Inc.'s subsequent filings and press releases for specific names, roles, and financial details related to the reported officer and director changes and compensatory arrangements, as these specifics will determine the true impact on the company's outlook.
Key Players & Entities
- Sabra Health Care REIT, Inc. (company) — the registrant filing the 8-K
- December 29, 2023 (date) — date of earliest event reported
- January 4, 2024 (date) — date the 8-K was filed
- 001-34950 (other) — Commission File Number for Sabra Health Care REIT, Inc.
- SBRA (other) — trading symbol for Sabra Health Care REIT, Inc. common stock
Forward-Looking Statements
- Sabra Health Care REIT, Inc. will release further details regarding the specific personnel changes and compensation arrangements mentioned in this 8-K. (Sabra Health Care REIT, Inc.) — high confidence, target: Q1 2024
- The market will react to the specific details of the executive changes and compensation, potentially causing short-term stock volatility. (SBRA stock price) — medium confidence, target: Within 1 month of detailed disclosure
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 29, 2023.
What specific items are covered in this 8-K filing by Sabra Health Care REIT, Inc.?
This 8-K filing covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.
What is the trading symbol for Sabra Health Care REIT, Inc. common stock?
The trading symbol for Sabra Health Care REIT, Inc. common stock is SBRA, and it is registered on The Nasdaq Stock Market LLC.
When was this 8-K filing submitted to the SEC?
This 8-K filing was filed as of January 4, 2024.
What is the business address and phone number of Sabra Health Care REIT, Inc. as listed in the filing?
The business address is 18500 Von Karman Avenue, Suite 550, Irvine, CA 92612, and the telephone number is (888) 393-8248.
Filing Stats: 1,202 words · 5 min read · ~4 pages · Grade level 10.7 · Accepted 2024-01-04 09:15:24
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value SBRA The Nasdaq Stock Market
- $400,000 — annual base salary will be increased to $400,000. Ms. Flores will also have a target bon
Filing Documents
- sbra-20231229.htm (8-K) — 41KB
- severancebenefitsagreement.htm (EX-10.1) — 47KB
- caoappointmentpr.htm (EX-99.1) — 4KB
- 0001492298-24-000003.txt ( ) — 238KB
- sbra-20231229.xsd (EX-101.SCH) — 2KB
- sbra-20231229_lab.xml (EX-101.LAB) — 26KB
- sbra-20231229_pre.xml (EX-101.PRE) — 13KB
- sbra-20231229_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 4, 2024, the Company issued a press release announcing the appointment of Ms. Flores as Executive Vice President and Chief Accounting Officer, as set forth in Item 5.02 of this Current Report on Form 8K. A copy of the press release regarding Ms. Flores's appointment is furnished as Exhibit 99.1 hereto. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 10.1 Severance Benefits Agreement, dated January 1, 2024, by and between Jessica Flores and Sabra Health Care REIT, Inc. 99.1 Press Release dated January 4, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SABRA HEALTH CARE REIT, INC. /S/ MICHAEL COSTA Name: Michael Costa Title: Executive Vice President, Chief Financial Officer and Secretary Date: January 4, 2024